164 related articles for article (PubMed ID: 25594011)
21. Specificity protein 1 (sp1) oscillation is involved in copper homeostasis maintenance by regulating human high-affinity copper transporter 1 expression.
Liang ZD; Tsai WB; Lee MY; Savaraj N; Kuo MT
Mol Pharmacol; 2012 Mar; 81(3):455-64. PubMed ID: 22172574
[TBL] [Abstract][Full Text] [Related]
22. Transcription factor Sp1 plays an important role in the regulation of copper homeostasis in mammalian cells.
Song IS; Chen HH; Aiba I; Hossain A; Liang ZD; Klomp LW; Kuo MT
Mol Pharmacol; 2008 Sep; 74(3):705-13. PubMed ID: 18483225
[TBL] [Abstract][Full Text] [Related]
23. The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae.
Lin X; Okuda T; Holzer A; Howell SB
Mol Pharmacol; 2002 Nov; 62(5):1154-9. PubMed ID: 12391279
[TBL] [Abstract][Full Text] [Related]
24. Mammalian copper homeostasis requires retromer-dependent recycling of the high-affinity copper transporter 1.
Curnock R; Cullen PJ
J Cell Sci; 2020 Aug; 133(16):. PubMed ID: 32843536
[TBL] [Abstract][Full Text] [Related]
25. Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells.
Beretta GL; Gatti L; Tinelli S; Corna E; Colangelo D; Zunino F; Perego P
Biochem Pharmacol; 2004 Jul; 68(2):283-91. PubMed ID: 15194000
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells.
Holzer AK; Katano K; Klomp LW; Howell SB
Clin Cancer Res; 2004 Oct; 10(19):6744-9. PubMed ID: 15475465
[TBL] [Abstract][Full Text] [Related]
27. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
Samimi G; Howell SB
Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571
[TBL] [Abstract][Full Text] [Related]
28. Promotion of cadmium uptake and cadmium-induced toxicity by the copper transporter CTR1 in HepG2 and ZFL cells.
Kwok ML; Li ZP; Law TYS; Chan KM
Toxicol Rep; 2020; 7():1564-1570. PubMed ID: 33294387
[TBL] [Abstract][Full Text] [Related]
29. Modulating Chemosensitivity of Tumors to Platinum-Based Antitumor Drugs by Transcriptional Regulation of Copper Homeostasis.
Lai YH; Kuo C; Kuo MT; Chen HHW
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772714
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals.
Liang ZD; Long Y; Chen HH; Savaraj N; Kuo MT
J Biol Inorg Chem; 2014 Jan; 19(1):17-27. PubMed ID: 24132751
[TBL] [Abstract][Full Text] [Related]
31. Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin.
Holzer AK; Manorek GH; Howell SB
Mol Pharmacol; 2006 Oct; 70(4):1390-4. PubMed ID: 16847145
[TBL] [Abstract][Full Text] [Related]
32. Dynamical interplay between the human high-affinity copper transporter hCtr1 and its cognate metal ion.
Walke G; Aupič J; Kashoua H; Janoš P; Meron S; Shenberger Y; Qasem Z; Gevorkyan-Airapetov L; Magistrato A; Ruthstein S
Biophys J; 2022 Apr; 121(7):1194-1204. PubMed ID: 35202609
[TBL] [Abstract][Full Text] [Related]
33. Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy.
Chen HH; Chen WC; Liang ZD; Tsai WB; Long Y; Aiba I; Fu S; Broaddus R; Liu J; Feun LG; Savaraj N; Kuo MT
Expert Opin Ther Targets; 2015; 19(10):1307-17. PubMed ID: 26004625
[TBL] [Abstract][Full Text] [Related]
34. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines.
Yoshizawa K; Nozaki S; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
Oncol Rep; 2007 Oct; 18(4):987-91. PubMed ID: 17786364
[TBL] [Abstract][Full Text] [Related]
35. Copper deprivation modulates CTR1 and CUP1 expression and enhances cisplatin cytotoxicity in Saccharomyces cerevisiae.
Kommuguri UN; Bodiga S; Sankuru S; Bodiga VL
J Trace Elem Med Biol; 2012 Jan; 26(1):13-9. PubMed ID: 22365074
[TBL] [Abstract][Full Text] [Related]
36. Core fucosylation of copper transporter 1 plays a crucial role in cisplatin-resistance of epithelial ovarian cancer by regulating drug uptake.
Lv X; Song J; Xue K; Li Z; Li M; Zahid D; Cao H; Wang L; Song W; Ma T; Gu J; Li W
Mol Carcinog; 2019 May; 58(5):794-807. PubMed ID: 30614075
[TBL] [Abstract][Full Text] [Related]
37. A role for the copper transporter Ctr1 in the synergistic interaction between hyperthermia and cisplatin treatment.
Landon CD; Benjamin SE; Ashcraft KA; Dewhirst MW
Int J Hyperthermia; 2013 Sep; 29(6):528-38. PubMed ID: 23879689
[TBL] [Abstract][Full Text] [Related]
38. Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells.
Kalayda GV; Wagner CH; Jaehde U
J Inorg Biochem; 2012 Nov; 116():1-10. PubMed ID: 23010323
[TBL] [Abstract][Full Text] [Related]
39. NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells.
Jiang P; Wu X; Wang X; Huang W; Feng Q
Oncotarget; 2016 Jul; 7(28):43337-43351. PubMed ID: 27270317
[TBL] [Abstract][Full Text] [Related]
40. The role of the mammalian copper transporter 1 in the cellular accumulation of platinum-based drugs.
Larson CA; Blair BG; Safaei R; Howell SB
Mol Pharmacol; 2009 Feb; 75(2):324-30. PubMed ID: 18996970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
